Skip to main content

Genesee Capital Advisors, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1652348 AUBURN, NY

Position in TEVA

as of Mar 31, 2026 · filed Apr 22, 2026
Position Value
$491,377
-$19,343 QoQ
Shares Held
16,314
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Genesee Capital Advisors, LLC holds $1,342,135 across 3 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (36.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 TEVA
Teva Pharmaceutical Industries Ltd
This page
16,314 $491,377

All Filings in TEVA

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $491,377 16,314
2025-12-31 $510,720 16,364
2025-09-30 $330,552 16,364
2025-06-30 $223,980 13,364
2025-03-31 $205,404 13,364
2024-12-31 $331,217 15,028
2024-09-30 $240,819 13,364
2024-06-30 $217,165 13,364
2024-03-31 $188,566 13,364
2023-12-31 $139,520 13,364
2023-09-30 $136,312 13,364
2023-06-30 $100,630 13,364
2023-03-31 $118,271 13,364
2022-12-31 $121,879 13,364
2022-09-30 $107,847 13,364
2022-06-30 $100,497 13,364
2022-03-31 $125,487 13,364
2021-12-31 $107,045 13,364
2021-09-30 $110,928 11,389
2021-03-31 $131,429 11,389
2020-12-31 $109,903 11,389
2020-09-30 $102,614 11,389
2020-06-30 $140,426 11,389
2020-03-31 $102,273 11,389